BCL2L11 and breast carcinoma: In this study we demonstrate that in MDA-MB-231 and MCF7 breast cancer cells, overexpression of UEV1A alone is sufficient to activate the AKT signaling pathway that in turn inhibits FOXO1 and BIM expression to promote cell survival under serum starvation stress and to enhance resistance to chemotherapy.